Medical and cellular implications of stunning, hibernation, and preconditioning: An NHLBI workshop

Circulation

Volumn 97, Issue 18, 1998, Pages 1848-1867

  Kloner, Robert A ^a,f   Bolli, Roberto ^b   Marban, Eduardo ^c   Reinlib, Leslie ^e   Braunwald, Eugene ^d  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF LOUISVILLE   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^f GOOD SAMARITAN HOSPITAL   (United States)

Author keywords

Hibernation; Infarction; Ischemia; Myocardial; Preconditioning; Stunning

Indexed keywords

CALCIUM ION; OXYGEN RADICAL;

CALCIUM TRANSPORT; CLINICAL TRIAL; CONFERENCE PAPER; HEART ARRHYTHMIA; HEART FAILURE; HEART MUSCLE BLOOD FLOW; HEART MUSCLE CONTRACTILITY; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; HUMAN; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; STUNNED HEART MUSCLE;

EID: 0032510660     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.97.18.1848     Document Type: Conference Paper

References (252)

1. Braunwald E, Kloner RA. The stunned myocardium: prolonged, postischemic ventricular dysfunction. Circulation. 1982;66:1146-1149.
2. Bolli R. Mechanism of myocardial 'stunning.' Circulation. 1990;82: 723-738.
3. Heyndrickx GR, Millard RW. McRitchie RJ. Maroko PR, Vatner F. Regional myocardial functional and electrophysiological alterations after brief coronary artery occlusion in conscious dogs. J Clin Invest. 1975;56:978-985.
4. Heyndrickx GR, Baig H, Nellens P, Leusen I, Fishbein MC, Vatner SF. Depression of regional blood flow and wall thickening after brief coronary occlusions. Am J Physiol. 1978;234:H653-H659.
5. Bolli R. Zhu WX, Thomby JI, O'Neill PC, Roberts R. Time-course and determinants of recovery of function after reversible ischemia in conscious dogs. Am J Physiol. 1988;254:H102-H114.
6. Przyklenk K, Kloner RA. Effect of verapamil on postischemic 'stunned' myocardium: importance of the timing of treatment. J Am Coll Cardiol. 1988;11:614-623.
7. Nicklas JM, Becker LC. Bulkley BH. Effects of repeated brief coronary occlusion on regional left ventricular function and dimension in dogs. Am J Cardiol. 1985;56:473-478.
8. Stahl LD, Aversano TR, Becker LC. Selective enhancement of function of stunned myocardium by increased flow. Circulation. 1986;74: 843-851.
9. Bolli R, Zughaib M, Li X-Y, Tang X-L, Sun J-Z, Triana JF, MeCay P, Recurrent ischemia in the canine heart causes recurrent bursts of free radical production that have a cumulative effect on contractile function: a pathophysiological basis for chronic myocardia) 'stunning,' J Clin Invest. 1995;96:1066-1084.
10. Stahl LD, Weiss HR, Becker LC. Myocardial oxygen consumption, oxygen supply/demand heterogeneity, and microvascular patency in regionally stunned myocardium. Circulation. 1988;77:865-872.
11. Cohen MV, Downey JM. Myocardial stunning in dogs: preconditioning effect and influence of coronary collateral flow. Am Heart J. 1990;120: 282-291.
12. Lavallee M, Cox D. Patrick TA, Vatner SF. Salvage of myocardial function by coronary artery reperfusion 1, 2, and 3 hours after occlusion in conscious dogs. Circ Res. 1983;53:235-247.
13. Bush LR, Buja LM, Samowitz W, Rude RE, Wathen M, Tilton GD, Willerson JT. Recovery of left ventricular segmental function after long-term reperfusion following temporary coronary occlusion in conscious dogs: comparison of 2- and 4-hour occlusions. Circ Res. 1983; 53:248-263.
14. 2+ activation of contraction as a consequence of reperfusion-lnduced cellular calcium overload in ferret hearts. J Clin Invest. 1987;79: 950-961.
15. 2+ transients underlie stunning? Circ Res. 1990; 66:1268-1276.
16. 19F NMR spectroscopy in intact ferret hearts. Proc Natl Acad Sci USA. 1987;84: 6005-6009.
17. 2+], in perfused hearts: critical evaluation of the 5F-BAPTA and nuclear magnetic resonance method as applied to the study of ischemia and reperfusion. Circ Res. 1990;66:1255-1267.
18. Ambrosio G, Weisfeldt ML, Jacobus WE, Flaherty JT. Evidence for a reversible oxygen radical-mediated component of reperfusion injury: reduction by recombinant human Superoxide dismutase administered at the time of reflow. Circulation. 1987;75:282-291.
19. Ambrosio G. Zweier JL, Jacobus WE. Weisfeldt ML, Flaherty JT. Improvement of postischemic myocardial function and metabolism induced by administration of desferrioxamine at the time of reflow: the role of iron in the pathogenesis of reperfusion injury. Circulation. 1987;76:906-915.
20. Gardner TJ. Oxygen radicals in cardiac surgery. Free Radie Biol Med. 1988;4:45-50.
21. Stewart JR. Blackwell WH, Crute SL, Loughlin V, Greenfield U, Hess ML. Inhibition of surgically induced ischemia/reperfusion injury by oxygen free radical scavengers. J Thorac Cardiovasc Surg. 1983;86: 262-272.
22. Johnson DL, Homeffer PS, Dinatale JM Jr. Gott VL, Gardner TJ. Free radical scavengers improve functional recovery of stunned myocardium in a model of surgical coronary revascularization. Surgery. 1987;102: 334-340.
23. Illes RW, Silverman NA, Krukenkamp IB, del Nido PJ, Levitsky S. Amelioration of postischemic stunning by deferoxamine-blood cardioplegía. Circulation. 1989;80(suppl III):III-30-III-35.
24. Homans DC, Sublett E, Dai XZ, Bache RJ. Persistence of regional left ventricular dysfunction after exercise-induced myocardial ischemia. J Clin Invest. 1986;77:66-73.
25. Homans DC, Laxon DD, Sublett E, Lindstrom P, Bache RJ. Cumulative deterioration of myocardial function after repeated episodes of exerciseinduced ischemia. Am J Physiot. 1989;256(Heart Circ Physiol 25): H1462-H1471.
26. Hittinger L, Shannon RP, Kohin S. Manders WT, Kelly P, Vatner SF. Exercise-induced subendocardial dysfunction in dogs with left ventricular hypertrophy. Circ Res. 1990;66:329-343.
27. Bolli R. Oxyradicals in the pathogenesis of myocardial stunning. In: Heyndrickx GR, Vatner SF, Wijns W, eds. Stunning, Hibernation, and Preconditioning: Clinical Pathophysiology of Myocardial Ischemia. Philadelphia, Pa: Lippincott-Raven Press; 1997:205-228.
28. Kusuoka H, Marban E. Cellular mechanism of myocardial stunning. Annu Rev Physiol. 1992;54:243-256.
29. Marban E, Koretsune Y, Corretti M, Chacko VP, Kusoka H. Calcium and its role in myocardial cell injury during ischemia and reperfusion. Circulation. 1989;80(suppl IV):IV-17-IV-22.
30. Myers ML, Bolli R, Lekich RF, Hartley CJ, Roberts R. Enhancement of recovery of myocardial function by oxygen free-radical scavengers after reversible regional ischemia. Circulation. 1985;72:915-921.
31. Przyklenk K, Kloner RA. Superoxide dismutase plus catalase improve contractile function in the canine model of the 'stunned' myocardium. Circ Res. 1986;58:148-156.
32. Gross GJ, Farber NE, Hardman HF, Warltier DC. Beneficial actions of Superoxide dismutase and catalase in stunned myocardium of dogs. Am J Physiol 1986;250:H372-H377.
33. Sun J-Z, Tang X-L, Park S-W, Qiu Y, Turrens J, Bolli R. Evidence for an essential role of reactive oxygen species in the genesis of late preconditioning against myocardial stunning in conscious pigs. J Clin Invest. 1996;97:562-576.
34. Shlafer M, Cane PF, Kirsh MM. Superoxide dismutase plus catalase enhances the efficacy of hypothermic cardioplegia to protect the globally ischemic, reperfused heart. J Thorac Cardiovasc Surg. 1982; 83:830-839.
35. Menasche P, Grossest C, Gauduel Y, Piwnica A. A comparative study of free radical scavengers in cardioplegic solutions: improved protection with peroxidase. J Thorac Cardiovasc Surg. 1986;92:264-271.
36. Ytrehus K, Gunnes S, Myklebust R, Mjos OD. Protection by Superoxide dismutase and catalase in the isolated rat heart reperfused after prolonged cardioplegia; a combined study of metabolic, functional and morphometric ultrastructural variables. Cardiovasc Res. 1987;21: 492-499.
37. Bolli R. Role of oxygen radicals in myocardial stunning. In: Kloner RA, Przyklenk K, eds. Stunned Myocardium: Properties, Mechanisms, and Clinical Manifestations. New York, NY: Marcel Dekker, 1993:155-195.
38. Triana JF, Li XY, Jamaluddin U, Thomby JI, Bolli R. Postischemic myocardial 'stunning': identification of major differences between the open-chest and the conscious dog and evaluation of the oxygen radical hypothesis in the conscious dog. Circ Res. 1991;69:731-747.
39. Sekili S, McCay PB, Li X-Y, Zughaib M, Sun JZ, Tang X-L, Thomby JI, Bolli R. Direct evidence that the hydroxyl radical plays a pathogenetic role in myocardial 'stunning' in the conscious dog and that stunning can be markedly attenuated without subsequent adverse effects. Circ Res. 1993;73:705-723.
40. Jeroudi MO, Triana FJ, Patel BS, Bolli R. Effect of Superoxide dismutase and catalase, given separately, on myocardial 'stunning.' Am J Physiol. 1990;259:H889-H901.
41. Buchwald A, Klein HH, Lindert S, Pich S, Nebendahl K, Wiegand V. Kreuzer H. Effect of intracoronary Superoxide dismutase on regional function in stunned myocardium. J Cardiovasc Pharmacol. 1989;13: 258-264.
42. Koerner JE, Anderson BA, Dage RC. Protection against postischemic myocardial dysfunction in anesthetized rabbits with scavengers of oxygen-derived free radicals: Superoxide dismutase plus catalase, N-2-mercaptopropionyl glycine and captopril. J Cardiovasc Pharmacol. 1991;17:185-191.
43. Bolli R, Jeroudi MO, Patel BS, Aruoma OI, Halliwell B, Lai EK, McCay PB. Marked reduction of free radical generation and contractile dysfunction by antioxidant therapy begun at the time of reperfusion: evidence that myocardial 'stunning' is a manifestation of reperfusion injury. Circ Res. 1989;65:607-622.
44. Bolli R, Patel BS, Jeroudi MO, Lai EK, McCay PB. Demonstration of free radical generation in 'stunned' myocardium of intact dogs with the use of the spin trap A-phenyl W-tert-butyl nitrone. J Clin Invest. 1988; 82:476-485.
45. Bolli R, Jeroudi MO, Patel BS, DuBose CM, Lai EK, Roberts R. McCay PB. Direct evidence that oxygen-derived free radicals contribute to postischemic myocardial dysfunction in the intact dog. Proc Natl Acad Sci U S A. 1989;86:4695-4699.
46. Bolli R, Patel BS, Jeroudi MO, Li XY, Triana JF, Lai EK, McCay PB. Iron-mediated radical reactions upon reperfusion contribute to myocardial 'stunning.' Am J Physiol, 1990;259:H1901-H1911.
47. Li XY, McCay PB, Zughaib M, Jeroudi MO, Triana JF, Bolli R. Demonstration of free radical generation in the 'stunned' myocardium in the conscious dog and identification of major differences between conscious and open-chest dogs. J Clin Invest. 1993;92:1025-1041.
48. Sun JZ, Kaur H, Halliwell B, Li XY, Bolli R. Use of aromatic hydroxylation of phenylalanine to measure production of hydroxyl radicals after myocardial ischemia in vivo: direct evidence for a pathogenetic role of the hydroxyl radical in myocardial stunning. Circ Res. 1993;73: 534-549.
49. Homans DC, Asinger R, Pavek T. Crampton M, Lindstrom P, Peterson D, Bache RJ. Effect of Superoxide dismutase and catalase on regional dysfunction after exercise-induced ischemia. Am J Physiol. 1992;263: H392-H398.
50. Hearse DC. Stunning: a radical review. In: Opie LH, ed. Stunning, Hibernation, and Calcium in Myocardial Ischemia and Reperfusion. Boston, Mass: Kluwer Academic Press; 1992:10-55.
51. O'Neill PG, Charlat ML, Michael LH, Roberts R, Bolli R. Influence of neutrophil depletion on myocardial function and flow after reversible ischemia. Am J Physiol. 1989;256:H341-H351.
52. Bolli R. Role of neutrophils in myocardial stunning after brief ischaemia: the end of a six-year-old controversy (1987-1993). Cardiovasc Res, 1993;27:728-730.
53. Dage RC, Anderson BA, Mao SJT, Koemer JE. Probucol reduces myocardial dysfunction during reperfusion after short-term ischemia in rabbit heart. J Cardiovasc Pharmacol, 1991;17:158-165.
54. 2+-pump activity by oxygen free radicals. Am J Physiol. 1989;256: H368-H374.
55. 2+ pump by oxygen free radicals. Am J Physiol. 1989; 257:H804-H811.
56. +-ATPase. Am J Physiol. 1987;252:H252-H257.
57. Reeves JP, Bailey CA, Hale CC. Redox modification of sodium-calcium exchange activity in cardiac sarcolemmal vesicles. J Biol Chem. 1986; 261:4948-4955.
58. Gao WD, Liu Y, Marban E. Selective effects of oxygen free radicals on excitation-contraction coupling in ventricular muscle: implications for the mechanism of stunned myocardium. Circulation. 1996;94: 2597-2604.
59. Rowe GT, Manson NH, Caplan M, Hess ML. Hydrogen peroxide and hydroxyl radical mediation of activated leukocyte depression of cardiac sarcuplasmic reticulnm: participation of the cydooxygenase pathway. Circ Res. 1983;53:584-591.
60. Carrozza JP, Bentivegna LA, Williams CP, Kuntz RE, Grossman W, Morgan JP. Decreased myofilament responsiveness in myocardial stunning follows transient calcium overload during ischemia and reperfusion. Circ Res. 1992;71:1334-1340.
61. 2+ sensitivity and altered diastolic function in intact ventricular muscle. Circ Res. 1995;76:1036-1048.
62. Krause SM, Jacobus WE, Becker LC. Alterations in cardiac sarcoplasmic reticulum calcium transport in the postischemic 'stunned' myocardium. Circ Res. 1989;65:526-530.
63. Kitakaze M, Weisfeldt ML, Marban E. Acidosis during early reperfusion prevents myocardial stunning in perfused ferret hearts. J Clin Invest. 1988;82:920-927.
64. Hofmann PA, Miller WP, Moss RL. Altered calcium sensitivity of isometric tension in myocyte-sized preparations of porcine postischemic stunned myocardium. Circ Res. 1993;72:50-56.
65. 2+ sensitivity of tension during stunning in porcine myocardium. J Moll Cell Cardiol. 1996;28:689-697.
66. Gao WD, Atar D, Liu Y, Perez NO, Murphy AM, Marban E. Role of troponin I proteolysis in the pathogenesis of stunned myocardium. Circ Res. 1997;80:393-399.
67. McDonald KS, Mammen PPA, Strang KT, Moss RL, Miller WP. Isometric and dynamic contractile properties of porcine skinned cardiac myocytes after stunning. Circ Res. 1995;77:964-972.
68. Ellis SO, Wynne J, Braunwald E, Henschke CI, Sandor T, Kloner RA. Response of reperfusion-salvaged, stunned myocardium to inotropic stimulation. Am Heart J. 1984;107:13-19.
69. Arnold JMO, Braunwald E, Sandor T, Kloner RA. Inotropic stimulation of reperfused myocardium: effects on infarct size and myocardial function. J Am Coll Cardiol. 1988;6:1026-1034.
70. Becker LC, Levine JH, DiPaula AF, Guarnieri T, Aversano T. Reversal of dysfunction in postischemic stunned myocardium by epinephrine and postextrasystolic potentiation. J Am Coll Cardiol. 1986;7:580-589.
71. 2+ responsiveness in stunned rat ventricular myocardium: relative roles of cytosolic factors versus structural alterations. Circ Res. 1996;78:455-465.
72. Sun J-Z, Tang X-L, Knowlton AA, Park S-W, Qiu Y, Bolli R. Late preconditioning against myocardial stunning: an endogenous protective mechanism that confers resistance to postischemic dysfunction 24 hours after brief ischemia in conscious pigs. J Clin Invest. 1995;95:388-403.
73. Shen Y-T, Vatner SF. Mechanism of impaired myocardial function during progressive coronary stenosis in conscious pigs: hibernation versus stunning? Circ Res. 1995;73:479-488.
74. Bolli R. Myocardial 'stunning' in man. Circulation. 1992;86:1671-1691.
75. i, and contractility during ischemia and reperfusion. Circulation. 1992;86(suppl II):II-371-II-376.
76. McCully JD, Tsukube T, Ataka K, Krukenkamp IB, Feinberg H, Levitsky S. Myocardial cytosolic calcium accumulation during ischemia/reperfusion: the effects of aging and cardioplegia. J Cardiothorac Surg. 1994;9:449-452.
77. Tsukube T, McCully JD, Faulk EA, Federman M. LoCicero J III, Krukenkamp IB, Levitsky S. Magnesium cardioplegia reduces cytosolic and nuclear calcium and DNA fragmentation in the senescent myocardium. Ann Thorac Surg. 1994;58:1005-1011.
78. Patel B, Kloner RA, Przyklenk K, Braunwald E. Postischemic myocardial 'stunning': a clinically relevant phenomenon. Ann Intern Med. 1988;108:626-629.
79. Kloner RA, Przyklenk K, Patel B. Altered myocardial states: the stunned and hibernating myocardium. Am J Med. 1989;86(suppl 1A):14-22.
80. Kloner RA, Przyklenk K, Rahimtoola S, Braunwald E. Myocardial stunning and hibernation: mechanisms and clinical implications. In: Braunwald E. ed. Heart Disease: Update II. Philadelphia, Pa: WB Saunders; 1990:241-256.
81. Touchstone DA, Beller GA, Nygaard TW, Tedesco C, Karl S. Effects of successful intravenous reperfusiun therapy on regional myocardial function and geometry in humans: a tomographic assessment using two-dimension echocardiography. J Am Coll Cardiol. 1989;13:1506-1513.
82. Stack RS, Phillips HR, Grierson D, Behar VS, Kong Y, Peter RH, Swain JL, Greentleld JC. Functional improvement of jeopardized myocardium following intracoronary streptokinase infusion in acute myocardial infarction. J Clin Invent. 1983;72:84-95.
83. Sheehan FH, Doerr R, Schmidt WG, Bolson EI, Uebis R, Von Essen R, Effert S, Dodge HT. Early recovery of left ventricular function after thrombolytic therapy for acute myocardial infarction: an ímportant determinant of survival. J Am Coll Cardiol. 1988;12:289-300.
84. Reduto LA, Freund GC, Gaeta JM, Smalling RW, Lewis B, Gould KL. Coronary artery reperfusion in acute myocardíal ínfarctíon: beneficial effects of intracoronary streptokinase on left ventricular salvage and performance. Am Heart J. 1981;102:1168-1177.
85. Satler LF, Kent KM, Fox LM, Goldstein HA, Green CE, Rogers WJ, Pallas RS, Del Negro AA, Pearle DL, Rackley CF. The assessment of contractile reserve after thrombolytic therapy for acute myocardial infarction. Am Heart J. 1986;111:821-825.
86. Kloner RA, Przyklenk K, Kay GL. Clinical evidence for stunned myocardium after coronary artery bypass surgery. J Cardiac Surg. 1994;9(suppl):397-402.
87. Gray R, Maddhai J, Herman D, Raymond M, Waxman A, Ganz W, Matloff J, Swan HJC. Scintigraphic and hemodynamic demonstration of transient left ventricular dysfunction immediately after uncomplicated coronary artery bypass grafting. J Thorac Cardiovasc Surg. 1979;77:504-510.
88. Breisblatt WM, Stein KL, Wolfe CJ, Follansbee WP, Capozzi J, Armitage JM, Hardesty RL. Acute myocardial dysfunction and recovery: a common occurrence after coronary bypass surgery. J Am Coll Cardiol. 1990;15:1261-1269.
89. Bolli R, Hartley CJ, Rabinovitz RS. Clinical relevance of myocardial 'stunning' In: Opie LH, ed. Stunning, Hibernation and Calcium in Myocardial Ischemia and Reperfusion. Boston, Mass: Kluwer Academic Publishers; 1992:56-82.
90. Kloner RA, Alien J, Cox TA, Zheng Y, Ruiz CE. Stunned left ventricular myocardium following exercise treadmill testing in coronary artery disease. Am J Cardiol. 1991;68:329-334.
91. Ambrosio G, Betocchi S, Pace L, Losi MA, Perrone-Filardi P, Soricelli A, Piscione F, Taube J, Squame F, Salvatore M, Weiss JL, Chiariello M. Prolonged impairment of regional contractile function after resolution of exercise-induced angina: evidence of myocardial stunning in patients with coronary artery disease. Circulation. 1996;94:2455-2464.
92. Fragasso G, Benti R, Sciammarella M, Rossetti E, Savi A, Gerundini P, Chierchia SL. Symptom-limited exercise testing causes sustained diastolic dysfunction in patients with coronary artery disease and low effort tolerance. J Am Coll Cardiol. 1991;17:1251-1255.
93. Wijns W, Serruys PW, Slager CJ, Grimm J, Kragenbuehl HP, Hugenholtz PG, Hess OM. Effect of coronary occlusion during percutaneous transluminal angioplasty in humans on left ventricular chamber stiffness and regional diastolic pressure radius relations. J Am Coll Cardiol. 1986;7:455-461.
94. Sheiban I, Tonni S, Marini A, Trevi G. Clinical and therapeutic implications of chronic left ventricular dysfunction in coronary artery disease. Am J Cardiol. 1995;75:22E-30E.
95. Nixon JV, Brown CN, Smitherman TC. Identification of transient and persistent segmental wall motion abnormalities in patients with unstable angina by two-dimensional echocardiography. Circulation. 1982;65:1497-1503.
96. Dorheim TA, Hoffman A, Van Wylen DGL, Mentzer RM. Enhanced interstitial fluid adenosine attenuates myocardial stunning. Surgery. 1991;110:136-145.
97. Sekili S, Jeroudi MO, Tang X-L, Zughaib M, Sun JZ, Bolli R. Effect of adenosine on myocardial 'stunning' in the dog. Circ Res. 1995;76:82-94.
98. Zughaib ME, Abd-Elfattah AS, Jeroudi MO, Sun JZ, Sekili S, Tang X-L, Bolli R. Augmentation of endogenous adenosine attenuates myocardial 'stunning' independently of coronary flow or hemodynamic effects. Circulation. 1993;88:2359-2369.
99. Auchampach JA, Maruyama M, Cavero I, Gross GJ. Pharmacological evidence for a role of ATP-dependent potassium channels in myocardial stunning. Circulation. 1992;86:311-319.
100. Przyklenk K, Kloner RA. Calcium antagonists as treatment for the stunned myocardium. In: Stunned Myocardium: Properties, Mechanisms, and Clinical Manifestations. New York, NY: Marcel Dekker Inc; 1993:281-301.
101. Heusch G. Myocardial stunning: a role for calcium antagonists during ischaemia? Cardiovasc Res. 1992;26:14-19.
102. Park SW, Tang XL, Qiu Y, Sun JZ, Bolli R. Nisoldipine attenuates myocardial stunning induced by multiple coronary occlusions in conscious pigs and this effect is independent of changes in hemodynamics or coronary blood flow. J Mol Cell Cardiol. 1996;28:655-666.
103. Zughaih ME, Sun JZ, Bolli R. Effect of angiotensin-converting enzyme inhibitors on myocardial ischemia/reperfusion injury: an overview. In: Grobecker H, Heusch G, Strauer BE, eds. Angimensin and the Heart. New York. NY: Springer-Verlag: 1993:156-157.
104. Ehring T, Baumgart D, Krajcar M, Hummelgen M, Kompa S, Heusch G. Attenuation of myocardial stunning by the ACE inhibitor ramiprilat through a signal cascade of bradykinin and prostaglandins but not nitric oxide. Circulation. 1994;90:1368-1385.
105. Rahimtoola S. Coronary bypass surgery for chronic angina-1981: a perspective. Circulation. 1982;65:225-241.
106. Rahimtoola SH. A perspective on the three large multicenter randomized clinical trials of coronary bypass surgery for chronic stable angina. Circulation. 1985;72(suppl V):V-123-V-135.
107. Rees G, Bristow JD, Kremkau EL, Green GS, Heir RH, Griswold HE, Starr A. Influence of aortocoronary bypass surgery on left ventricular performance. N Engl J Med. 1971;284:1116-1120.
108. Chatterjee K, Swan HJC, Parmley WW, Sustaita H, Marcus HS, Matloff J. Influence of direct myocardial revascularization on left ventricular asynergy and function in patients with coronary disease. Circulation. 1973;47:276-286.
109. Horn HR, Teichholz LE, Conn PF, Herman MV, Gorlin R. Augmentation of left ventricular contraction pattern in coronary artery disease by an inotropic catecholamine: the epinephrine ventriculogram. Circulation. 1974;49:1063-1071.
110. Dyke SH, Conn PF, Gorlin R, Sonnenblick EH. Detection of residual myocardial function in coronary artery disease using post-extra systolic potentiation. Circulation. 1974;50:694-699.
111. Rozanski A, Berman D, Gray R, Diamond G, Raymond M, Prause J, Maddahi J, Swan HJC, Matloff J. Preoperative prediction of reversible myocardial asynergy by postexercise radionuclide ventriculography. N Engl J Med. 1982;307:212-216.
112. Diamond GA, Forrester JS, deLuz PL, Wyatt HL, Swan HJC. Postextrasystolic potentiation of ischemic myocardium by atrial stimulation. Am Heart J. 1978;95:204-209.
113. Rahimtoola SH. The hibernating myocardium. Am Heart J. 1989;117: 211-221.
114. Braunwald E, Rutherford JD. Reversible ischemic left ventricular dysfunction: evidence for the hibernating myocardium. J Am Coll Cardiol. 1986;8:1467-1470. Editorial.
115. Marban E. Myocardial stunning and hibernation: the physiology behind the colloquialisms. Circulation. 1991;83:681-688.
116. Chatterjee K, Swan HJC, Parmley WW, Sustaita H, Marcus H, Matloff J. Depression of left ventricular function due to acute myocardial ischemia and its reversal after aortocoronary saphenous vein bypass. N Engl J Med. 1972;286:1117-1122.
117. Nienaber CA, Brunken RC, Sherman CT, Yeatman LA, Gambhir SS, Krivokapich J, Demer LL, Ratib O, Child JS, Phelps ME, Scheiben HR. Metabolic and functional recovery of ischemic human myocardium after coronary angioplasty. J Am Coll Cardiol. 1991;18:966-978.
118. Brundage BH, Massie BM, Botvinick EH. Improved regional ventricular function after successful surgical revascularization. J Am Coll Cardiol. 1984;3:902-908.
119. Rankin JS, Newman GE, Muhlbaier LH, Behar VS, Fedor JM, Sabiston DC Jr. The effect of coronary revascularization on ventricular function in ischemic heart disease. J Thorac Cardiovasc Surg. 1985;90:818-832.
120. Tillisch J, Brunken R, Marshall R, Schwaiger M, Mandelkern M, Phelps M, Scheiben H. Reversibility of cardiac wall motion abnormalities predicted by positron emission tomography. N Engl J Med. 1986;314: 884-888.
121. Cohen M, Charney R, Hershman R, Fuster V, Gorlin R, Xavier F. Reversal of chronic ischemic myocardial dysfunction after transluminal coronary angioplasty. J Am Coll Cardiol. 1988;12:1193-1198.
122. Topol EJ, Weiss JL, Guzman PA, Dorsey-Lima S, Blanck TJJ, Humphrey LS, Baumgartner WA, Flaherty JT, Reitz BA. Immediate improvement of dysfunctional myocardial segments after coronary revascularization: detection by intraoperative transesophageal ecnocardiography. J Am Coll Cardiol. 1984;4:1123-1134.
123. Baker WB, Klein MS, Reardon MJ, Verani MS, Zoghbi WA. Reversible cardiac dysfunction (hibernation) from ischemia due to compression of the coronary arteries by a pseudoaneurysm. N Engl J Med. 1991;325: 1858-1861.
124. Rahimtoola SH. Myocardial hibernation: current clinical perspectives. In: Yellon DM, Rahimtoola SH, Opie LH, eds. New Ischemic Syndromes. Phíladelphía, Pa: Lippincott-Raven Publishers;. 1997:215-234.
125. Breisblatt WM, Brown DL, Weiland FL. Reversibility of long-standing left ventricular aneurysm predicted by thallium-201 imaging. J Am Coll Cordíol. 1986;7:1162-1166.
126. Akins CW, Pohost GM, DeSanctis RW, Block PC. Selection of angina-free patients with severe left ventricular dysfunction for myocardial revascularization. Am J Cordial. 1980;46:695-700.
127. Nesto RW, Conn LH, Collins JJ Jr, Wynne J, Homan L, Cohn PF. Inotropic contractile reserve: a useful predictor of increased 5 year survival and improved postoperative left ventricular function in patients with coronary artery disease and reduced ejection fraction. Am J Cardiol. 1982;50:39-44.
128. Helfant RH, Pine R, Meister SO, Feldman MS, Trout RG, Banka VS. Nitroglycerin to unmask reversible asynergy: correlation with post coronary bypass ventriculography. Circulation. 1974;50:108-113.
129. Kloner RA, Przyklenk K. Hibernation and stunning of the myocardium. N Engl J Med. 1991;325:1877-1879.
130. 201T1 imaging in detection of myocardial viability and prediction of improvement in left ventricular function after coronary bypass surgery in patients with severely depressed left ventricular function. Circulation, 1993;87:1630-1641.
131. Shivalkar B, Maes A, Borgers M, Ausma J, Scheys I, Nuyts J, Mortelmans L, Flameng W. Only hibernating myocardium invariably shows early recovery after coronary revascularization. Circulation. 1996;94:308-315.
132. Vom Dahl J, Altehoefer C, Sheehan FH, Buechin P, Uebis R, Messmer BJ, Buell U, Hanrath P. Recovery of regional left ventricular dysfunction after coronary revascularization. J Am Coll Cardiol. 1996;28: 948-958.
133. Gerwitz H, Fischman AJ, Abraham S, Gilson M, Strauss HW, Alpert NM. Positron emission tomographic measurements of absolute regional myocardial blood flow permits identification of nonviable myocardium in patients with chronic myocardial infarction. J Am Coll Cardiol. 1994;23:851-859.
134. Schwarz ER, Przyklenk K, Dahl JV, Schoendube FA, Hanrath P, Kloner RA. Chronic hibernating myocardium: concepts and controversies. Congestive Heart J. 1997;3:12-23.
135. Vanoverschelde JL, Wijns W, Depre C, Essamri B, Heyndrickx GR, Borgers M, Bol A, Melin JA. Mechanisms of chronic regional postischemic dysfunction in humans: new insights from the study of noninfarcted collateral-dependent .myocardium. Circulation. 1993;87: 1513-1523.
136. Marinho NVS, Keogh BE, Costa DC, Lammertsma AA, Ell PJ, Camici PG. Pathophysiology of chronic left ventricular dysfunction: new insights from the measurement of absolute myocardial blood flow and glucose utilization. Circulation. 1996;93:734-744.
137. Conversano A, Walsh JF, Geltman EM, Perez JE, Bergmann SP, Gropler RJ. Delineation of myocardial stunning and hibernation by positron emission tomography in advanced coronary artery disease. Am Heart J. 1996;131:440-450.
138. Gerber BL, Vanoverschelde J-L, Bol A, Michel C, Labar D, Wijns W, Melin JA. Myocardial blood flow, glucose uptake and recruitment of inotropic reserve in chronic left ventricular ischemic dysfunction: implications for the pathophysiology of chronic hibernation. Circulation. 1996;94:651-659.
139. Gropler RJ, Geltman EM, Sampathkumaran K, Perez JE, Moerlein SM, Sobel BE, Bergmann SR, Siegel BA. Functional recovery after coronary revascularization for chronic coronary artery disease is dependent on maintenance of oxidative metabolism. J Am Coll Cardiol. 1992;20: 569-577.
140. Hendel RC, Chaudhry FA, Bonow RO. Myocardial viability. Curr Probl Cardiol. 1996;21:145-224.
141. Scheiben HR. Metabolic imaging to assess myocardial viability. J Nucl Med. 1994;35:8S-14S.
142. Sun DT, Czemin J, Krivokupich J. Lau Y-K, Bottcher M, Maurer G, Phelps ME, Scheiben HR. Effects of dobutamine stimulation on myocardiul bloud flow, glucose metabolism, and wall motion in normal and dysfunctional myocardium. Circulation. 1996;94:3146-3154.
143. Marwick TH, MacIntyre WJ, Lafont A, Nemec JJ, Salcedo EE. Metabolic responses of hibernating and infarcted myocardium to revascularization: a follow-up study of regional perfusion, function, and metabolism. Circulation. 1992;85:1347-1353.
144. Dilsizian V, Bonow RO. Current diagnostic techniques of assessing myocardial viability in hibernating and stunned myocardium. Circulation. 1993;87:1-20.
145. Bonow RO. Identification of viable myocardium. Circulation. 1996;94: 2674-2680.
146. Maddahi J, Scheiben H, Brunken R, Di Carli M. Role of thallium-201 and PET imaging in evaluation of myocardial viability and management of patients with coronary artery disease and left ventricular dysfunction. J Nucl Med. 1994;35:707-715.
147. 201Tl seintigraphy and low-dose dobutamine echocardiography for the noninvasive assessment of myocardial viability. Circulation. 1996;94:2681-2684.
148. La Canna G, Alfieri O, Giubbini R, Gargano M, Ferrari R, Visioli O. Echocardiography during infusion of dobutamine for identification of reversible dysfunction in patients with chronic coronary artery disease. J Am Coll Cardiol. 1994;23:617-626.
149. Sawada S, Eisner G, Segar DS, O'Shaughnessy M, Khouri S, Foltz J, Bopurdillion PD, Bates JR, Fineberg N, Ryan T, Hutchins GD. Evaluation of patterns of perfusion and metabolism in dobutamineresponsive myocardium. J Am Coll Cardiol. 1997;29:55-61.
150. Heusch G, Schulz R. Recruitment of an inotropic reserve in hibernating and stunned myocardium. In: Opie LH, ed. Stunning, Hibernation, and Calcium in Myocardial Ischemia and Reperfusion. Norwell, Mass: Kluwer Academic Publishers; 1992:235-250.
151. McGhie AI, Weyman A. Searching for hibernating myocardium: time to reevaluate investigative strategies? Circulation. 1996;94:2685-2686.
152. Maes A, Flameng W, Nuyts J, Borgers M, Shivalkar B, Ausma J, Bormans G, Schiepers C, De Roo M, Mortelmans L. Histological alterations in chronically hypoperfused myocardium: correlation with PET findings. Circulation. 1994;90:735-745.
153. Borgers M, Thone F, Wouters L, Ausma J, Shivalkar B, Flameng W. Structural correlates of regional myocardial dysfunction in patients with critical coronary stenosis: chronic hibernation? Cardiovasc Pathol. 1993;2:237-245.
154. Schwarz ER, Schaper J, vom Dahl J, Altehoefer C, Grohmann B, Schoendube F, Sheehan FH, Uebis R, Buell U, Messmer BJ, Schaper W, Hanrath P. Myocyte degeneration and cell death in hibernating human myocardium. J Am Coll Cardiol. 1996;7:1577-1585.
155. Rahimtoola SH. Hibernating myocardium has reduced blood flow at rest that increases with low-dose dobutamine. Circulation. 1996;94:3055-3061.
156. Schulz R, Guth BD, Pieper K, Martin C, Heusch G. Recruitment of an inotropic reserve in moderately ischemic myocardium at the expense of metabolic recovery: a model of short-term hibernation. Circ Res. 1992;70:1282-1295.
157. Arai AE, Pantely GA, Thoma WJ, Anselone CG, Brístow JD. Energy metabolism and contractile function after 15 beats of moderate myocardial ischemia. Circ Res. 1992;70:1137-1145.
158. Matsuzaki M, Gallagher KP, Kemper WS, White F, Ross J Jr. Sustained regional dysfunction produced by prolonged coronary stenosis: gradual recovery after reperfusion. Circulation. 1983;68:170-182.
159. Pantely GA, Malone SA, Rhen WS, Anselone CG, Arai A, Bristow J, Bristow JD. Regeneration of myocardial phosphocreatinine in pigs despite continued moderate ischemia. Circ Res. 1990;67:1481-1493.
160. Fedele FA, Gerwirtz H, Capone RJ, Sharaf B, Most AS. Metabolic response to prolonged reduction of myocardial blood flow distal to a severe coronary artery stenosis. Circulation. 1988;78:729-735.
161. Canty JM, Fallavollita JA. Hibernating myocardium represents a primary downregulation of regional myocardial oxygen consumption distal to a critical stenosis. Basic Res Cardiol. 1995;90:5-8.
162. Canty JM, Klocke FS. Reduction in regional myocardial function at rest in conscious dogs with chronically reduced regional coronary artery pressure. Circ Res. 1987;61(suppl II):107-116.
163. Mills I, Fallon JT, Wrenn D, Sasken H, Gray W, Brier S, Levine D, Herman S, Gilson M, Gerwtiz H. Adaptive responses of coronary circulation and myocardium to chronic reduction in perfusion pressure and tlow. Am J Physiol. 1994;266(Heart Circ Physiol 35):H447-H457.
164. Ross J Jr. Myocardial hibernation, stunning, or both? In: Heusch G, Schulz R, eds. New Paradigms of Coronary Artery Disease: Hibernation. Stunning. Ischemic Preconditioning. New York. NY: Springer; 1996:42-44.
165. Heyndrickx GR. Hibernating myocardium. In: Heusch G, Schulz R, eds. New Paradigms of Coronary Artery Disease: Hibernation, Stunning, Ischemic Preconditioning. New York, NY: Springer; 1996:36-38.
166. Shen YT, Kudej RK, Bishop SP. Vatner SF, Inotropic reserve and histological appearance of hibernating myocardium in conscious pigs with ameroid-induced coronary stenosis. Basic Res Cardiol. 1996;91: 479-485.
167. Bonow RO. The hibernating myocardium: implications for the management of congestive heart failure. Am J Cardiol. 1995;75:17A-25A.
168. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 1986; 75:1124-1136.
169. Kloner RA. Yellon D. Does ischemic preconditioning occur in patients? J Am Coll Cardiol. 1994;24:1133-1142.
170. Nao BS, McClanahan TB, Oroh MA, Schott RJ, Gallagher KP. The time limit of effective ischemic preconditioning in dogs. Circulation. 1990; 82(suppl III):III-271. Abstract.
171. Marber MS, Latchman DS. Walker JM, Yellon DM. Cardiac stress protein elevation 24 hours after brief ischemia or heat stress is associated with resistance to myocardial infarction. Circulation. 1993;88: 1264-1272.
172. Kazuya T, Hashida S, Yamashita N, Fuji H, Oe H, Hori M, Kamada T, Tada M. Delayed effects of sublethal ischemia on the acquisition of tolerance to ischemia. Ore Res. 1993;72:1293-1299.
173. Yamashita N, Kuzuya T, Hoshida S, Nishida M, Igarashi J, Hori K, Kamada T, Tada M. A 'second window of protection' occurs 24 hours after ischemic preconditioning in rat heart. J Mol Cell Cardiol. 1995; 27:A517. Abstract.
174. Kaeffer N, Richard V, Thuillcz C. Delayed beneficial effects of preconditioning against repetfusion-induced coronary endothelial dysfunction. Eur Heart J. 1996;17:P1501. Abstract.
175. Murry CD, Richard VJ, Reimer KA, Jennings RB. Ischemic preconditioning slows energy metabolism and delays ultrastructural damage during a sustained ischemic episode. Circ Res. 1990;66:913-931.
176. Hagar JM, Hale SL, Kloner RA. Effect of preconditioning ischemia on reperfusion arrhythmias after coronary artery occlusion and reperfusion , in the rat. Circ Res. 1991;68:61-68.
177. Shihi K, Hearse DJ. Preconditioning of ischemic myocardium: reperfusion-induced arrhythmias. Am J Physiol. 1987;253: H1470-H1476.
178. Asimakis GK, Inners-McBride K, Medellen G, Conti VR, Ischemic preconditioning attenuates acidosis and postischemic dysfunction in isolated rat heart. Am J Physiol. 1992;263:H887-H894.
179. Ovize M, Przyklenk K, Kloner RA. Preconditioning does not attenuate myocardial stunning. Circulation. 1992;85:2247-2254.
180. Connaughton M, Hearse DJ. Three questions about preconditioning. Basic Res Cardiol. 1996;91:12-15.
181. Przyklenk K, Kloner RA. Preconditioning: a balanced perspective. Br Heart J. 1995;74:575-577.
182. Jennings RB. Overview of preconditioning against lethal cell injury. In: Marber MS, Yellon DM, eds. Ischemia: Preconditioning and Adaptation. Oxford, UK: Bios Scientific Publisher; 1996.
183. Cohen MV, Downey JM. Ischaemic preconditioning: can the protection be bottled? Lancet. 1993;324:6.
184. Liu GS, Thornton J, Van Winkle DM, Stanley AWH, Olsson DA, Downey JM. Protection against infarction afforded by preconditioning is mediated by AI adenosine receptors in rabbit heart. Circulation. 1991; 84:350-356.
185. Ytrehus Y, Liu Y, Downey JM. Preconditioning protects ischemic rabbit heart by protein kinase C activation. Am J Physiol. 1994;226: H1145-H1152.
186. Cohen MV, Liu Y, Liu GS, Wang P, Weinbrenner C, Condis GA, Das DK, Downey JM. Phospholipase plays a role in ischemic preconditioning in the rabbit heart. Circulation, 1996;94:1713-1718.
187. Goto M, Liu Y, Yang X-M, Ardelle JL, Cohen MV, Downey JM. The role of bradykinin in protection of ischemic preconditioning in rabbit hearts. Circ Res. 1995;77:611-621.
188. Cohen MV, Liu Y, Liu G, Wang P, Weinbrenner C, Cordis GA, Das DK, Downey JM. Phospholipase D plays a role in ischemic preconditioning in rabbit heart. Circulation. 1996;94:1713-1718.
189. Hale SL, Bellows SD, Hammerman H, Kloner RA. An adenosine A, receptor agonist, R(-)-N-(2-phenylisopropyl)-adenosine (PIA), but not adenosine itself, acts as a therapeutic preconditioning-mimetic agent in rabbits. Cardiovasc Res. 1993;27:2140-2145.
190. Li Y, Kloner RA. Does protein kinase C play a role in ischemic preconditioning in rat hearts? Am J Physiol. 1995;268:H426-H431.
191. Baines CP, Goto M, Downey JM. Oxygen radical release during ischemic preconditioning triggers protection in rabbit myocardium via activation of protein kinase C. Circulation. 1996;94(suppl I):I-424. Abstract.
192. Baines CP, Goto M, Downey JM. Oxygen radicals released during ischemic preconditioning contribute to cardioprotection in the rabbit myocardium. J Mol Cell Cardinl. 1997;29:207-216.
193. Tritto I, D'Andrea D, Eramo N, Scognamiglio A, Simone CD, Violante A, Esposito A, Chiarello M, Ambrosio G. Oxygen radicals can induce preconditioning in rabbit hearts. Circ Res. 1997;80:743-748.
194. Baines CP, Cohen MV, Downey JM. Protein tryosine kinase inhibitor, genistein, blocks preconditioning in isolated rabbit hearts. Circulation. 1996;94(suppl I):I-661. Abstract.
195. Armstrong SC, Downey JM, Canote CE. Preconditioning of isolated rabbit cardiomyocytes: induction by metabolic stress and blockade by the adenosine antagonist SPT and calphostin C. a protein kinase C inhibitor. Cardiavasc Res. 1994;28:72-77.
196. Armstrong SC, Canote CE. Preconditioning of isolated rabbit cardiomyocytes: effects of glycolytic blockade, phorbol esters, and ischemia, Cardiovasc Res. 1994;28:1700-1706.
197. Kitakaze M, Hori M. Takashima S. Sato H, Inoue M, Kamada T. Ischemic preconditioning increases adenosine release and 5'nucleotidase activity during myocardial ischemia and reperfusion in dogs: implications for myocardial salvage. Circulation. 1993;87:208-215.
198. Przyklenk K, Hata K, Kloner RA. Is calcium a mediator of infarct size reduction with preconditioning in canine myocardium? Circulation. 1997;96:1305-1312.
199. Przyklenk K, Zhao L, Kloner RA, Elliott GT. Cardioprotection with ischemic preconditioning and MLA: role of adenosine-regulating enzymes? Am J Physiol. 1997;271:H1004-H1014.
200. Przyklenk K, Hata K, Zhao L, Kloner RA, Elliott GT. Disparate effects of preconditioning and MLA on 5'NT and adenosine levels during coronary occlusion. Am J Physiol. 1997;273:H945-H951.
201. Ovize M, Loufoua J, Gysembergh A, Andre-Foucet X, Mincore Y. Role of tyrosine phosphorylation in ischemic preconditioning. Circulation. 1996;94(suppl I):I-661. Abstract.
202. Shipolini AR, Aalinones M, Edmondson SJ, Hearse SJ, Avkiran M. Activation of the Na/H exchanger is not causally involved in ischemic preconditioning. Circulation. 1996;94(suppl I):I-424. Abstract.
203. Przyklenk K, Sussman MA, Simkhovich BZ, Kloner RA. Does ischemic preconditioning trigger translocation of protein kinase C in the canine model? Circulation. 1995;92:1546-1557.
204. Vogt AM, Htun P, Arras M, Podzaweit T, Schaper W. Intramyocardial infusion of tool drugs for the study of molecular mechanisms in ischemic preconditioning. Basic Res Cardiol. 1996;91:389-400.
205. Valhaus C, Schulz R, Post H, Onallch R, Heusch A. No prevention of ischemic preconditioning by the protein kinase C inhibitor staurosporine in swine. Circ Res. 1996;79:407-414.
206. Ping P, Zhang J, Qiu Y, Tang XL, Manchikalapudi S, Cao X, Bolli R. Ischemic preconditioning induces selective translocation of PKC isoforms ε and η in the heart of conscious rabbits without subcellular redistribution of total protein kinase C activity. Circ Res. 1997;81: 404-414.
207. Goldberg M, Zhang HL, Steinberg SF. Hypoxia alters the subcellular distribution of protein kinase C isoforms on neonatal rat ventricular myocytes. J Clin Invest. 1996;99:55-61.
208. Mitchell MB, Meng X, Ao L, Brown JM, Harker AH, Banerjee A. Preconditioning of isolated rat heart mediated by protein kinase C. Circ Res. 1995;76:73-81.
209. Brooks A, Hearse DJ. Role of protein kinase C in ischemic preconditioning: player or spectator? Circ Res. 1996;79:627-630.
210. Armstrong SC, Gao W, Lane JR, Canote CE. Protein phosphatase inhibitors Calyculin A and Fostriecin protect rabbit cardiomyocytes in late ischemia. J Mol Cell Cardiol. 1998;30:61-74.
211. Gross GJ, Auchampach JA. Blockade of ATP sensitive potassium channels prevents myocardial preconditioning in dogs. Circ Res. 1992; 70:223-233.
212. Auchampach JA, Grover GJ, Gross GJ. Blockade of ischemic preconditioning in dogs by the novel ATP dependent potassium channel antagonist 5-hydroxydecanoate. Cardiovasc Res. 1992;26:1054-1062.
213. Yao Z, Gross GJ. Acetylcholine mimics ischemic preconditioning via a glibenclamide-sensitive mechanism in dogs. Am J Physiol. 1993;264: H2221-H2235.
214. ATP channels. Circulation. 1994;89:1229-1236.
215. Fralix TA, Steenbergen C, London RE, Murphy E. Glibenclamide does not abolish the protective effect of preconditioning on stunning in the isolated perfused rat heart. Cardiovasc Res. 1993;27:630-637.
216. Liu Y, Downey JM. Ischemic preconditioning protects against infarction in rat heart. Am J Physiol. 1992;263:H1107-H1112.
217. Thornton JD, Thornton DL, Sterling DL, Downey JM. Blockade of ATP-sensitive potassium channels increases infarct size but does not prevent preconditioning in rabbit hearts. Circ Res. 1993;72:44-49.
218. Schultz JEJ, Yao Z, Cavero I, Gross GJ. Glibenclamide-induced blockade of ischemic preconditioning is time dependent in intact rat heart. Am J Physiol. 1997;272:H2607-H2615.
219. Yellon DM, Baxter GF. 'A second window of protection' or delayed preconditioning phenomenon: future horizons for myocardial protection? J Mol Cell Cardiol. 1995;27:1023-1024.
220. Marber MS, Latchman DS, Walker JM, Yellon DM. Cardiac stress protein elevation 24 hours after brief ischemia or heat stress is associated with resistance to myocardial infarction. Circulation. 1993;88: 1264-1272.
221. Speechly-Dick ME, Mocanu MM, Yellon DM. Protein kinase C: its role in ischemic preconditioning in the rat. Circ Res. 1994;75:586-590.
222. Baxter GP, Goma FM, Yellon DM. Characterization of the infarctlimiting effect of delayed preconditioning: time course and dose dependency studies in rabbit myocardium. Basic Res Cardiol. 1997;92: 159-167.
223. Baxter GF, Marber MS, Patel VC, Yellon DM. Adenosine receptor involvement in a delayed phase of protection 24 hours following ischemic preconditioning. Circulation. 1994;90:2993-3006.
224. Baxter GF, Goma FM, Yellon DM. Involvement of protein kinase C in the delayed cytoprotection following sublethal ischaemia in rabbit myocardium. Br J Pharmacol. 1995;115:222-224.
225. Marber MS, Mestril R, Chi SH, Sager R, Yellon DM, Dillmann WH. Overexpression of the rat inducible 70-kd heat stress protein in a transgenic mouse increases the resistance of the heart to ischemic injury. J Clin Invest. 1995;95:1446-1456.
226. Sun JZ, Tang XL, Knowlton AA, Park SW, Qui YM, Bolli R. Late preconditioning against myocardial stunning: an endogenous protective mechanism that confers resistance to postischemic dysfunction 24 hours after brief ischemia in conscious pigs. J Clin Invest, 1995;95:388-403.
227. Sun JZ, Tang XL, Park SW, Qiu Y, Turrens JF, Bolli R. Evidence for an essential role of reactive oxygen species in the genesis of late preconditioning against myocardial stunning in conscious pigs. J Clin Invest. 1996;97:562-576.
228. Bolli R, Bhatti ZA, Tang X-L, Qiu Y, Zhang Q, Quo Y, Yadoon AK. Evidence that late preconditioning against myocardial stunning in conscious rabbits is triggered by the generation of nitric oxide. Circ Res. 1997;81:42-52.
229. Qiu Y, Rizvi A, Tang X-L, Manchikalapudi S, Takano H, Jadoon AK, Wu W-J, Bolli R. Nitric oxide triggers late preconditioning against myocardial infarction in conscious rabbits. Am J Physiol. 1997;273: H2931-H2936.
230. Qiu Y, Tang X-L, Park S-W, Sun J-Z, Kalya A, Bolli R. The early and late phase of ischemic preconditioning: a comparative analysis of their effect on infarct size, myocardial stunning, and arrhythmias in conscious pigs undergoing a 40-minute coronary occlusion. Circ Res. 1997;80: 730-742.
231. Zimmer SD, Bache RJ. Metabolic correlates of reversibly injured myocardium. In: Kloner RA. Przyklenk K, eds. Stunned Myocardium: Properties, Mechanisms and Clinical Manifestations. New York, NY: Marcel Dekker Inc; 1993:41-70.
232. Murry CE, Richard VJ, Jennings RB, Reimer KA. Myocardial protection is lost before contractile function recovers from ischemic preconditioning. Am J Physiol. 1991;260:H796-H804.
233. Matsuda M, Catena TG. Vander Heide RS, Jennings RB, Reimer KA. Cardiac protection by ischaemic preconditioning is not mediated by myocardial stunning. Cardiovasc Res. 1993;27:585-592.
234. Ikonomidis JS, Weisel RD, Mickle DAG. Ischemic preconditioning: cardioprotection for cardiac surgery. J Card Surg. 1994;9(suppl): 526-531.
235. Yellon DM, Alkulaif AM, Pugsley WB. Preconditioning the human myocardium. Lancet. 1993;342:276-277.
236. Jenkins DP, Pugsley WB, Alkhuiaifi AM, Kemp M, Hooper J, Yellon DM. Ischaemk preconditioning reduces troponin T release in patients undergoing coronary artery bypass surgery. Heart. 1997;77:314-318.
237. Walker DM, Walker JM, Pugsley WB, Pattison CW, Yellon DM. Preconditioning in isolated superfused human muscle. J Mol Cell Cardiol. 1995;27:1349-1357.
238. Speechly-Dick ME, Graver GJ, Yellon DM. Does ischemic preconditioning in the human involve protein kinase C and the ATP-dependent K+ channel? Circ Res. 1995;77:1030-1035.
239. Deutsch E, Berger M, Kussmaul WG, Hirshfeld JW, Herrman HC, Lashey WL. Adaptation to ischemia during percutaneous transluminal coronary angioplasty: clinical, hemodynamic, and metabolic features. Circulation. 1990;82:2044-2051.
240. Cribier A, Korsatz L, Koning R, Rath P, Gamra H, Stix G, Merchant S, Chan C, Letac B. Improved myocardial ischemic response and enhanced collateral circulation with long repetitive coronary occlusion during angioplasty: a prospective study. J Am Coll Cordial. 1992;20:578-586.
241. Leesar MA, Stoddard M, Ahmed M, Broadbent J, Bolli R. Preconditioning of human myocardium with adenosine during coronary angioplasty. Circulation. 1997;95:2500-2507.
242. Tomai F, Crea F, Gaspardone A, Versaci F, De Paulis R, Polisca P, Chiariello L, Gioffre PA. Effects of A adenosine receptor blockade by bamiphylline on ischaemic preconditioning during coronary angioplasty. Eur Heart J. 1996;17:846-853.
243. Claeys MJ, Vrints CJ, Bosnians JM, Concraads VM, Snoeck JP. Aminophylline inhibits adaptation to ischemia during angioplasty: role of adenosine in ischaemic preconditioning. Eur Heart J. 1996;17:539-544.
244. Kloner RA, Shook T, Przyklenk K, Davis VG, Junio L, Matthews RV, Burstein S, Gibson M, Poole WK, Cannon CP, McCabe C, Braunwald E, for TIMI Investigators. Previous angina alters in-hospital outcome in TIMI 4: a clinical correlate to preconditioning? Circulation, 1995;91: 37-47.
245. Ottani F, Galvani M, Ferrini D, Sorbello F, Limonetti P, Pantoli D, Rusticali F. Prodromal angina limits infarct size: a role for ischemic preconditioning. Circulation. 1995;21:291-297.
246. Anzai T, Yoshikawa T, Asakura Y, Abe S, Meguno T, Akaishi M, Mitamura H, Handa S, Ogawa S. Effect on short-term prognosis and left ventricular function of angina pectoris prior to first Q-wave anterior wall acute myocardial infarction. Am J Cardiol. 1994;74:755-759.
247. Kloner RA, Shook T, Antman EM, Cannon CP, Przyklenk K, McCabe CH, Braunwald E, TIMI 9 Investigators. A prospective analysis on the potential preconditioning effect of preinfarct angina in TIMI 9. Circulation. 1996;94(suppl I):I-611. Abstract.
248. Ishihara M, Sato H, Tateishi H, Kawagoe T, Shimatani Y, Kurisu S, Sakai K, Ueda K. Implications of prodromal angina pectoris in anterior wall acute myocardial infarction: acute angiographic findings and long-term prognosis. J Am Coll Cardiol. 1997;30:970-975.
249. Andreotti F, Pasceri V, Hackett DR, Davies GJ, Harder AW, Maseri A. Preinfarction angina as a predictor of more rapid coronary thrombolysis in patients with acute myocardial infarction. N Engl J Med. 1996; 334:7-12.
250. Okazaki Y, Kodama K, Sato H, Mafasumi K, Atsushi H, Masayoshi M, Masatsugu H, Michitoshi I. Attenuation of increased regional myocardial oxygen consumption during exercise as a major cause of warm-up phenomenon. J Am Coll Cardiol. 1993;21:1597-1604.
251. Maybaum S, Ilan M, Mogilevsky J, Tzivoni D. Improvement in ischemic parameters during repeated exercise testing: a possible model for myocardial preconditioning. Am J Cardiol. 1996;78:1087-1091.
252. Mentzer RM Jr, Rahko PS, Molina-Viamonte V, Canver CC, Chopra PS, Love RL, Cook TD, Hegge JO, Lasley RD. Safety, tolerance, and efficacy of adenosine as an additive to blood cardioplegia in humans during coronary artery bypass surgery. Am J Cardiol. 1997;79(suppl 12A):38-43.